Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation

被引:293
作者
Conen, David [1 ,2 ,3 ]
Chae, Claudia U. [3 ]
Glynn, Robert J. [3 ]
Tedrow, Usha B. [2 ,4 ]
Everett, Brendan M. [3 ,4 ]
Buring, Julie E. [3 ]
Albert, Christine M. [2 ,3 ,4 ]
机构
[1] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland
[2] Harvard Univ, Sch Med, Dept Med, Ctr Arrhythmia Prevent,Brigham & Womens Hosp, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Med, Div Prevent Med,Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Univ, Sch Med, Dept Med, Cardiovasc Div,Brigham & Womens Hosp, Boston, MA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 20期
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
CONGESTIVE-HEART-FAILURE; FOLLOW-UP; ALCOHOL-CONSUMPTION; PREDICTING STROKE; NATURAL-HISTORY; SECULAR TRENDS; BLOOD-PRESSURE; MORTALITY; COMMUNITY; PREVALENCE;
D O I
10.1001/jama.2011.659
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The risks associated with new-onset atrial fibrillation (AF) among middle-aged women and populations with a low comorbidity burden are poorly defined. Objectives To examine the association between incident AF and mortality in initially healthy women and to evaluate the influence of associated cardiovascular comorbidities on risk. Design, Setting, and Participants Between 1993 and March 16, 2010, 34 722 women participating in the Women's Health Study underwent prospective follow-up. Participants were 95% white, older than 45 years (median, 53 [interquartile range {IQR}, 49-59] years), and free of AF and cardiovascular disease at baseline. Cox proportional hazards models with time-varying covariates were used to determine the risk of events among women with incident AF. Secondary analyses were performed among women with paroxysmal AF. Main Outcome Measures Primary outcomes included all-cause, cardiovascular, and noncardiovascular mortality. Secondary outcomes included stroke, congestive heart failure, and myocardial infarction. Results During a median follow-up of 15.4 (IQR, 14.7-15.8) years, 1011 women developed AF. Incidence rates per 1000 person-years among women with and without AF were 10.8 (95% confidence interval [CI], 8.1-13.5) and 3.1 (95% CI, 2.9-3.2) for all-cause mortality, 4.3 (95% CI, 2.6-6.0) and 0.57 (95% CI, 0.5-0.6) for cardiovascular mortality, and 6.5 (95% CI, 4.4-8.6) and 2.5 (95% CI, 2.4-2.6) for noncardiovascular mortality, respectively. In multivariable models, hazard ratios (HRs) of new-onset AF for all-cause, cardiovascular, and noncardiovascular mortality were 2.14 (95% CI, 1.64-2.77), 4.18 (95% CI, 2.69-6.51), and 1.66 (95% CI, 1.19-2.30), respectively. Adjustment for nonfatal cardiovascular events potentially on the causal pathway to death attenuated these risks, but incident AF remained associated with all mortality components (all-cause: HR, 1.70 [95% CI, 1.30-2.22]; cardiovascular: HR, 2.57 [95% CI, 1.63-4.07]; and noncardiovascular: HR, 1.42 [95% CI, 1.02-1.98]). Among women with paroxysmal AF (n=656), the increase in mortality risk was limited to cardiovascular causes (HR, 2.94; 95% CI, 1.55-5.59). Conclusion Among a group of healthy women, new-onset AF was independently associated with all-cause, cardiovascular, and noncardiovascular mortality, with some of the risk potentially explained by nonfatal cardiovascular events. JAMA. 2011; 305(20): 2080-2087
引用
收藏
页码:2080 / 2087
页数:8
相关论文
共 34 条
[1]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[2]   Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women [J].
Conen, David ;
Tedrow, Usha B. ;
Cook, Nancy R. ;
Moorthy, M. V. ;
Buring, Julie E. ;
Albert, Christine M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2489-2496
[3]   Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women [J].
Conen, David ;
Tedrow, Usha B. ;
Koplan, Bruce A. ;
Glynn, Robert J. ;
Buring, Julie E. ;
Albert, Christine M. .
CIRCULATION, 2009, 119 (16) :2146-2152
[4]   Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials [J].
Dagenais, Gilles R. ;
Pogue, Janice ;
Fox, Kim ;
Simoons, Marteen L. ;
Yusuf, Salim .
LANCET, 2006, 368 (9535) :581-588
[5]   Antithrombotic strategies for atrial fibrillation: on the threshold of changes? Yes [J].
Di Pasquale, G ;
Casella, G .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (03) :428-432
[6]   Comparison of the impart of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study) [J].
Friberg, J ;
Scharling, H ;
Gadsboll, N ;
Truelsen, T ;
Jensen, GB .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) :889-894
[7]   Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF) [J].
Friberg, Leif ;
Hammar, Niklas ;
Pettersson, Hans ;
Rosenqvist, Marten .
EUROPEAN HEART JOURNAL, 2007, 28 (19) :2346-2353
[8]  
Fried Linda P., 1991, Annals of Epidemiology, V1, P263
[9]   ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, David S. ;
Crijns, Harry J. ;
Curtis, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Le Heuzey, Jean-Yves ;
Kay, G. Neal ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, Samuel .
CIRCULATION, 2006, 114 (07) :E257-E354
[10]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870